Exagen, Inc.
(NASDAQ: XGN)

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

7.200

-0.290 (-3.87%)
Range 7.190 - 7.540   (4.87%)
Open 7.490
Previous Close 7.490
Bid Price 3.110
Bid Volume 14
Ask Price 3.490
Ask Volume 8
Volume 148,703
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis